LexaGene Holdings Inc. (LXXGF)
Stock analysis · OTC · Healthcare · Medical - Devices
LexaGene Holdings Inc. (LXXGF) is a publicly traded company in the Healthcare sector. Latest price: $0.08. Market cap $11.34M. Trailing PE -0.90. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About LexaGene Holdings Inc.
LexaGene Holdings Inc. is a biotechnology firm dedicated to the innovation, development, and market release of systems designed for identifying pathogens. Its core offering is MiQLab, an automated pathogen detection platform poised to revolutionize how pathogens are detected in diverse fields, including veterinary and human clinical diagnostics, food and water safety analysis, and other life science applications. This cutting-edge system can be deployed directly where samples are collected, providing exceptional user-friendliness, precise sensitivity, and a broad scope for pathogen identification. The company was established in 2007 and operates from its headquarters in Beverly, Massachusetts.
Valuation
| P/E (TTM) | -0.90× |
|---|---|
| P/S (TTM) | 150.51× |
| P/B | 1.52× |
| P/FCF (TTM) | -1.17× |
| EV / EBITDA | -0.78× |
| EV / Sales | 104.37× |
| Earnings Yield | -109.82% |
| Free Cash Flow Yield | -85.25% |
Fundamentals
| Enterprise Value | $7.86M |
|---|---|
| Revenue (TTM) | $75.31K |
| Net Income (TTM) | -$12.45M |
| Free Cash Flow (TTM) | -$9.59M |
| Net Debt | -$3.48M |
| Working Capital | $5.65M |
| Gross Margin | -621.40% |
| Operating Margin | -14124.86% |
| Net Margin | -14100.96% |
| Return on Equity | -123.04% |
| Return on Invested Capital | -139.24% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap